Acts synergistically within the NAD+ salvage pathway, combining Niacinamide's barrier-building and melanosome-blocking activity with NMN's cellular NAD+ boosting energy.
Read the passport엔엠엔 · 전성분 · Living ingredient passport
NMN
A cutting-edge NAD+ precursor that recharges cellular energy (ATP), enhances mitochondrial function, and suppresses melanogenesis to repair skin barrier damage and reverse signs of photoaging.
- INCI
- NICOTINAMIDE MONONUCLEOTIDE
Also called Beta-Nicotinamide Mononucleotide · β-NMN · Nicotinamide Mononucleotide
This ingredient page is still early. We're actively researching before it's ready to stand fully on its own — check back as more sections are verified.
The short answer
Four lines, each compressed from the section it links to. Every line carries the sources of the claim it compresses.
- What it does
Melanin Production Reduction in Aged Melanocytes
See the evidence - Where it goes
serum or moisturizer step · day and night
See how to use it - What shows, and when
Immediate: Skin hydration, softening, and initial barrier conditioning.
See the timeline
How to use it
Where it sits in the seven-step ladder, and the record's own fields for the habit.
day and night
Filled steps are where NMN commonly appears. No product is recommended.
Everything here comes from the sources below. None of it is a product recommendation.
- Time of day
- day and night
- Where it sits
- serum or moisturizer step
- Starting frequency
- daily
- Amount
- moderate amount (1-2 pumps or a few drops of serum)
- Application
- Apply evenly to clean, dry face, neck, and chest as an active serum or cream. Gently pat to promote absorption.
- Storage
- Store in a cool, dry place away from direct heat and light. Keep container tightly sealed.
Plays well with / keep apart
One card per pair. Where the partner has its own passport, the name links to it.
Do layer it with
What to expect, and when
The record's own timeline. Each step keeps the source of the study it came from.
- Immediate
Skin hydration, softening, and initial barrier conditioning.
Is this safe for me
Everything the record says about suitability, consolidated. Pause-first comes first.
Before you start
Highly stable and exceptionally safe for topical use. No known photosensitivity or major adverse reactions reported.
Best match
aging skin
hyperpigmentation · damaged skin barrier · dull complexion · photoaged skin
Routine
serum or moisturizer step
Pregnancy and breastfeeding
Not medical advice · ask your own clinician
Pregnancy. A 2011 dermatology review of skin-care product safety in pregnancy names hydroquinone (high systemic absorption) and tretinoin (evidence controversial) as the actives of concern, and states that most other topical skin-care products act locally and produce minimal systemic absorption; NMN is not named among the flagged concerns 3. This is general topical-product reasoning rather than an ingredient-specific safety trial. If you are pregnant, ask your doctor before use.
Breastfeeding. Topical application is applied locally with minimal expected systemic absorption; no ingredient-specific breastfeeding safety trial was located. As a general precaution common to topical actives, avoid applying directly to the breast or nipple area, since incidental transfer to a nursing infant has not been studied for this ingredient. If you are breastfeeding, ask your doctor before use.
| Common, and it usually settles | Stop using it |
|---|---|
| None typically expected. NMN is exceptionally biocompatible and non-irritating. | persistent redness |
| localized itching | |
| burning sensation | |
| rash |
Allergen history
A dedicated search of the peer-reviewed literature (PubMed) for topical NMN / nicotinamide mononucleotide allergic contact dermatitis, contraindication, and sensitization case reports found none.
Who should not use it
Research in progress — check back soon. How we verify
What it will not do
- The 3D human skin model melanin-reduction results demonstrated with 1.0 mM NMN cannot be assumed for wash-off cleansers due to negligible skin contact time.
- The systemic metabolic anti-aging findings from oral NMN dietary supplementation cannot be directly equated to localized topical skin benefits.
- The deep mitochondrial NAD+ boosting effects of pure crystalline Beta-NMN cannot be assumed for crude, unpurified fermentation byproducts.
The evidence
One card per claim. Concentration, form, population and limitation sit with it, always visible.
- Indicative
- Limited
- Moderate
- Strong
Melanin Production Reduction in Aged Melanocytes
IndicativeSignificantly reduces melanin production in aged melanocytes and 3D reconstituted human skin models by downregulating cAMP/Wnt signaling.1
- Tested concentration
- 1.0 mM (approx 0.033%)
- Which form
- Beta-Nicotinamide Mononucleotide (β-NMN)
- Population and duration
- Primary human melanocyte cell cultures and 3D human skin equivalents evaluated over 72 to 120 hours
- Limitation
- Selective depigmenting effect observed specifically in aged melanocytes rather than young baseline melanocytes.
Large-scale, multi-center, double-blind, randomized controlled human clinical trials assessing topical NMN monotherapy (1.0% cream) on facial photoaging and wrinkle depth over 12 weeks.
The research packet's headline photoaging-reversal claim (wrinkle formation, skin barrier function, hydration and elasticity) rests on a real animal study whose own delivery route is oral supplementation, not the topical cosmetic application this record covers. This record does not map that claim, and does not map the mechanism citation, pairing rationale, or usage-timeline text that depended on it.
Questions & related
Common questions · 자주 묻는 질문
What is NMN in skincare and how does it work?
Can NMN help fade dark spots and hyperpigmentation?
The clinical recordHow it works · Forms · Manufacturing · Regulations · Study ledger · Gaps · Sources
How it works
NMN is a direct biochemical precursor to Nicotinamide Adenine Dinucleotide (NAD+). Intracellularly it converts to NAD+, activating sirtuin longevity enzymes (SIRT1, SIRT3) and enhancing mitochondrial ATP energy production 2, and it downregulates cAMP/Wnt melanogenesis signaling in aged melanocytes.
- Intracellular NAD+ Biosynthesis and Sirtuin Activation
Converts to NAD+ within cells, activating SIRT1 to promote mitochondrial biogenesis, DNA repair, and antioxidant superoxide dismutase (SOD) defense.
What that rests on: in-vitro and pre-clinical assays
Source2
- cAMP/Wnt Melanogenesis Downregulation in Aged Melanocytes
Selectively downregulates forskolin-induced cAMP/Wnt signaling in aged melanocytes, reducing tyrosinase expression and melanin synthesis in 3D skin models.
What that rests on: 3D human skin model and cell culture
Source1
Reading the label
- Find this name
- 엔엠엔 (NMN) — a NAD+ precursor used for cellular vitality and anti-aging in K-beauty serums.
- Terms that may mislead
- Not on the MFDS publicly notified functional list, so brands co-dose it with Adenosine 0.04% or Niacinamide 2%-5% for simplified functional cosmetic reporting.
- Judge production transparency
- Manufacturers disclose HPLC purity, optical rotation, heavy metal COAs, and microbiological profiles. Proprietary enzyme sequences are kept confidential.
| Attribute | Beta-Nicotinamide Mononucleotide (β-NMN) |
|---|---|
| What it is | The biologically active beta-anomer that directly converts to NAD+ in human cells. |
| Official INCI | NICOTINAMIDE MONONUCLEOTIDE |
| Where it comes from | Biotechnological enzymatic synthesis or microbial fermentation |
| How it is made | Produced via enzymatic conversion of nicotinamide and ribose using nicotinamide phosphoribosyltransferase (NAMPT) or bio-fermentation, followed by ultrafiltration, crystallization, and freeze-drying to isolate pure crystalline β-NMN powder. |
How it is actually made
- Origin regions: South Korea, Japan, China, United States
- Manufactured via biotechnological enzymatic synthesis using nicotinamide phosphoribosyltransferase (NAMPT) or microbial fermentation using yeast or E. coli vectors, followed by crystallization and purification.
- Controlled by HPLC assay ensuring >= 99.0% Beta-NMN active content, with strict limits on heavy metals (<= 10 ppm), moisture (<= 1.0%), and microbial purity.
- Manufacturers disclose HPLC purity, optical rotation, heavy metal COAs, and microbiological profiles. Proprietary enzyme sequences are kept confidential.
Where the ceiling is set
European Union
- The rule
- EU Cosmetics Regulation (EC) No 1223/2009
- What it allows
- Listed in the CosIng database (ref 94540) under NICOTINAMIDE MONONUCLEOTIDE (CAS 1094-61-7) with the function antioxidant -- a function listing, not a regulatory approval or safety determination.
South Korea
- The rule
- Ministry of Food and Drug Safety (MFDS) Cosmetics Safety Standards
- What it allows
- Not found on any MFDS restricted-ingredient list. Not on the MFDS publicly notified functional list, requiring co-dosing with Adenosine (0.04%) or Niacinamide (2%-5%) for simplified functional cosmetic reporting.
What the evidence rests on
Study records
Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling
NMN treatment markedly reduced melanin synthesis in aged melanocytes and 3D human skin equivalents by downregulating cAMP/Wnt signaling, with no cytotoxicity observed.
Where it falls shortSelective anti-melanogenic effect observed specifically in aged melanocytes rather than young baseline cells.
Source1
The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update
NMN is a key NAD+ precursor that increases NAD+ concentrations, activates sirtuins, mitigates oxidative stress, DNA damage, and inflammatory responses with high safety across human oral-supplementation trials.
Where it falls shortReviews oral NAD+ supplementation trials only; makes no topical or cosmetic-application claim.
Source2
What is still missing
Large-scale, multi-center, double-blind, randomized controlled human clinical trials assessing topical NMN monotherapy (1.0% cream) on facial photoaging and wrinkle depth over 12 weeks.
The exact quantitative wrinkle-depth reduction of topical NMN monotherapy on human facial skin remains an approximation, as key in-vivo datasets currently rely on animal photoaging models and 3D human skin equivalents.
NeedsA randomized, double-blind, vehicle-controlled human trial evaluating 1.0% topical NMN cream vs vehicle on 100 photoaged human subjects over 12 weeks.
The research packet's headline photoaging-reversal claim (wrinkle formation, skin barrier function, hydration and elasticity) rests on a real animal study whose own delivery route is oral supplementation, not the topical cosmetic application this record covers. This record does not map that claim, and does not map the mechanism citation, pairing rationale, or usage-timeline text that depended on it.
This record cannot state that topical NMN reverses photoaging or repairs skin barrier function in a real, verified topical trial. The general cellular NAD+/sirtuin mechanism is still supported, and the melanin-reduction claim is separately mapped and unaffected, but the flagship photoaging-reversal benefit is not established for topical use.
NeedsA topical or cutaneous NMN study, in any concentration and population, that measures skin barrier function, wrinkle formation, hydration or elasticity against a vehicle or untreated control.
Sources on file
- Brito S, Baek JM, Cha B, Heo H, Lee SH, Lei L, Jung SY, Lee SM, Lee SH, Kwak BM, Chae S, Lee MG, Bin BH. Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. J Dermatol Sci (2022)(opens in a new tab)
- Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr (2023)(opens in a new tab)
- Bozzo, Chua-Gocheco & Einarson. Can Fam Physician (2011)(opens in a new tab)